Yumiko Ishii
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Early versus delayed dupilumab differentially restores IL-13-induced airway barrier dysfunction.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: March 31, 2026
Epigenetic Dysregulation of the NKX2-1/SPDEF Axis Drives Persistent Goblet Cell Differentiation and Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary Disease.
Journal: Respirology (Carlton, Vic.)
Published: September 06, 2025
Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series.
Journal: The journal of allergy and clinical immunology. Global
Published: September 24, 2024
Claudin-3 deficiency inhibits allergic responses in an ovalbumin-induced asthma mouse model.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: July 07, 2024
Lemborexant-induced interstitial lung disease: A case report.
Journal: Respirology case reports
Published: February 15, 2024
Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.
Journal: Frontiers in immunology
Published: March 24, 2023
Inhibition of PI3Kδ Differentially Regulates Poly I:C- and Human Metapneumovirus-Induced PD-L1 and PD-L2 Expression in Human Bronchial Epithelial Cells.
Journal: Frontiers in immunology
Published: September 09, 2021
Incense smoke-induced oxidative stress disrupts tight junctions and bronchial epithelial barrier integrity and induces airway hyperresponsiveness in mouse lungs.
Journal: Scientific reports
Published: December 18, 2020
Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37.
Journal: Respiratory research
Published: June 03, 2019
Frequency-dependent airway hyperresponsiveness in a mouse model of emphysema and allergic inflammation.
Journal: Physiological reports
Published: October 02, 2017
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
Journal: Scientific reports
Published: February 24, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026